Publications by authors named "Friedrich Overkamp"

Claim this Profile
[
[A look into the neighboring discipline: eHealth in oncology].
Friedrich Overkamp

Chirurgie (Heidelb)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Return of individual genomic research results within the PRAEGNANT multicenter registry study.
Hanna Huebner, Matthias Ruebner, Christian Kurbacher, Peyman Hadji, Andreas D Hartkopf, Friedrich Overkamp

Breast Cancer Res Treat· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).
Markus Moehler, Gunnar Folprecht, Volker Heinemann, Julian Walter Holch, Annett Maderer, Friedrich Overkamp

Int J Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status.
Alexander Hein, Andreas D Hartkopf, Julius Emons, Michael P Lux, Bernhard Volz, Friedrich Overkamp

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis.
Peter A Fasching, Siddhartha Yadav, Chunling Hu, Marius Wunderle, Lothar Häberle, Friedrich Overkamp

J Clin Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2020 Part 5 - Moving Therapies From Advanced to Early Breast Cancer Patients.
Michael P Lux, Andreas Schneeweiss, Andreas D Hartkopf, Volkmar Müller, Wolfgang Janni, Friedrich Overkamp

Geburtshilfe Frauenheilkd· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer.
Diana Lüftner, Andreas D Hartkopf, Michael P Lux, Friedrich Overkamp, Hans Tesch

Breast Care (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diagnosis and therapy of tumors with NTRK gene fusion].
Albrecht Stenzinger, Cornelis M van Tilburg, Ghazaleh Tabatabai, Florian Länger, Norbert Graf, Friedrich Overkamp

Pathologe· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany".
Andreas Schneeweiss, Johannes Ettl, Diana Lüftner, Matthias W Beckmann, Erik Belleville, Friedrich Overkamp

Breast· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany.
Andreas Schneeweiss, Johannes Ettl, Diana Lüftner, Matthias W Beckmann, Erik Belleville, Friedrich Overkamp

Breast· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2020 Part 3 - Early Breast Cancer.
Jens Huober, Andreas Schneeweiss, Andreas D Hartkopf, Volkmar Müller, Michael P Lux, Friedrich Overkamp

Geburtshilfe Frauenheilkd· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer.
Hans Tesch, Volkmar Müller, Achim Wöckel, Johannes Ettl, Erik Belleville, Friedrich Overkamp

Geburtshilfe Frauenheilkd· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine.
Elena Laakmann, Julius Emons, Florin-Andrei Taran, Wolfgang Janni, Sabrina Uhrig, Friedrich Overkamp

Geburtshilfe Frauenheilkd· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany.
Hanna Huebner, Christian M Kurbacher, Geoffrey Kuesters, Andreas D Hartkopf, Michael P Lux, Friedrich Overkamp

BMC Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine.
Elena Laakmann, Julius Emons, Florin-Andrei Taran, Wolfgang Janni, Sabrina Uhrig, Friedrich Overkamp

Geburtshilfe Frauenheilkd· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab.
Laura L Michel, Andreas D Hartkopf, Peter A Fasching, Hans-Christian Kolberg, Peyman Hadji, Friedrich Overkamp

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC).
Carl Christoph Schimanski, Stefan Kasper, Susanna Hegewisch-Becker, Jan Schröder, Friedrich Overkamp

Oncoimmunology· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics.
Diana Lüftner, Andreas Schneeweiss, Andreas D Hartkopf, Volkmar Müller, Achim Wöckel, Friedrich Overkamp

Geburtshilfe Frauenheilkd· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2020 Part 1 - Early Breast Cancer: Consolidation of Knowledge About Known Therapies.
Andreas Schneeweiss, Andreas D Hartkopf, Volkmar Müller, Achim Wöckel, Michael P Lux, Friedrich Overkamp

Geburtshilfe Frauenheilkd· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational Highlights in Breast and Ovarian Cancer 2019 - Immunotherapy, DNA Repair, PI3K Inhibition and CDK4/6 Therapy.
Andreas D Hartkopf, Volkmar Müller, Achim Wöckel, Michael P Lux, Wolfgang Janni, Friedrich Overkamp

Geburtshilfe Frauenheilkd· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2019 Part 4 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer.
Florian Schütz, Peter A Fasching, Manfred Welslau, Andreas D Hartkopf, Achim Wöckel, Friedrich Overkamp

Geburtshilfe Frauenheilkd· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2019 Part 5 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer.
Manfred Welslau, Andreas D Hartkopf, Volkmar Müller, Achim Wöckel, Michael P Lux, Friedrich Overkamp

Geburtshilfe Frauenheilkd· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apps and More: Potentials of Digitalization in Breast Medicine.
Friedrich Overkamp

Breast Care (Basel)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2019 Part 3 - Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel.
Hans-Christian Kolberg, Andreas Schneeweiss, Tanja N Fehm, Achim Wöckel, Jens Huober, Friedrich Overkamp

Geburtshilfe Frauenheilkd· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2019 Part 2 - Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice.
Wolfgang Janni, Andreas Schneeweiss, Volkmar Müller, Achim Wöckel, Michael P Lux, Friedrich Overkamp

Geburtshilfe Frauenheilkd· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis